Fred Alger Management, LLC

SEC CIK: 0000003520
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by Fred Alger Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overview All 13F holders of SYRE Full Q2 2026 holdings

Shares (Q2 2026): 28,834
Value: $2.56M
% of portfolio: <0.1%
Quarters held: 3; Since Q1 2024

Holdings of SYRE by Fred Alger Management, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	28,834	$2.56M	<0.1%	−30,619−51.5%	Reduced	Holders
Q1 2026	59,453	$3.00M	<0.1%	+59,453	New	Holders
Q2 2024	0	$0	0.0%	−18,158−100.0%	Sold out	Holders
Q1 2024	18,158	$688.7K	<0.1%	+18,158	New	Holders